Statins: Is It Safe and Effective to Use Generic “Equivalents”?
Authors:
- Cynthia A. JackeviciusCJCynthia A. Jackevicius
- Jack V. TuJTJack V. Tu
- Harlan M. KrumholzHKHarlan M. Krumholz
- 1 April 2013
- journal article
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 29 (4) , 408-410
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Generic Atorvastatin and Health Care CostsNew England Journal of Medicine, 2012
- Effect of Two Intensive Statin Regimens on Progression of Coronary DiseaseNew England Journal of Medicine, 2011
- Amiodarone-induced thyroid dysfunction: brand-name versus generic formulationsCanadian Medical Association Journal, 2011
- Physician Perceptions About Generic DrugsAnnals of Pharmacotherapy, 2011
- Efficacy and tolerability of a generic and a branded formulation of atorvastatin 20 mg/d in hypercholesterolemic Korean adults at high risk for cardiovascular disease: A multicenter, prospective, randomized, double-blind, double-dummy clinical trialClinical Therapeutics, 2010
- Patients’ Perceptions Of Generic MedicationsHealth Affairs, 2009
- Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular DiseaseJAMA, 2008
- Beliefs about generic drugs among elderly adults in hospital-based primary care practicesPatient Education and Counseling, 2008
- What is “quality of evidence” and why is it important to clinicians?BMJ, 2008
- Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statinsThe Lancet, 2005